Ventipeep, a respiratory mask, has been saving more than 1200 lives of Covid-19 patients across major hospitals in the country since its launch on 1 July 2020, says the company. Introduced by Flextool Equipment after successful trials at Nair and Hinduja hospitals in Mumbai, Ventipeep is a respiratory mask developed to administer supplemental oxygen (medically referred to as FiO2). It is not only utilized in ICU wards but is also useful in regulating the oxygen levels in Covid-19 and ARDS patient wards. The mask is an aid to small hospitals that lack infrastructure as it helps reduce the time needed for treatment and can be used in any ward of the hospital.
According to the company, the Ventipeep is a twin port mask. However, to differentiate, the new mask has a first of its kind high flow oxygen driver that can take care of high flow oxygen therapy, replacing the HFNO Machine and also a PEEP valve that can control the Positive End-Expiratory Pressure (PEEP) in the lungs of the patient, allowing the equipment to work like a BiPAP with a High Flow Oxygen Therapy System. High flow oxygen reduces the black spots in the windpipe and replaces all carbon content with oxygen. PEEP maintains positive pressure in the lungs, allowing it to exchange the gases at a faster rate.
Ventipeep is used as a non-invasive ventilator, it said. Normally a Ventilator, BiPAP, CPAP, and other treatments require experts and are expensive. Hospitals have a limited number of devices and can be used on a limited number of patients. In the present scenario, the demand for ICU beds is extremely high. Approximately 35% of Covid-19 patients have required a ventilator during treatment. Ventipeep can be used on a regular hospital bed and does not require an ICU bed, does not need the intervention of an expert, and can be operated by any non-medical staff as well. Therefore, it considerably reduces the cost of operation, unlike a ventilator. As compared to treatment with ventilators, Ventipeep assures higher lifesaving capacity.
“Owing to the lockdown and its worsening scenario, we envisaged creating a revolutionary product to address the lack of a solution to the challenges faced by the ICU wards and the overall medical infrastructure of India. Along with Dr Parthiv Shah – TB Chest Specialist, we developed a high flow oxygen therapy to create a prototype, which could be used without an HFNO machine in any ward of a hospital, in May,” says Purvang Shah, Director of Ventipeep. Once the mask was tested and useful for Covid-19 patients, Purvang started manufacturing Ventipeep in small batches. Currently, this respiratory mask is gaining hospitals hospitals’ attention to save patients’ lives admitted to the ICU and, most importantly, Covid-19 patients. Apart from hospital wards, Ventipeep can be utilized as a lifesaving device in ambulances during emergencies.
“The idea is to reduce the fatality rate and improve the recovery rate of Covid-19 and ARDS Patients in India and across the world. As we continue our quest to develop innovative products for the betterment of healthcare in our country, we anticipate the active participation of private & public hospitals, government, institutes, medical and para medical goal is to support Prime Minister Narendra Modi’ vision of ”Atmanirbhar Bharat” by manufacturing medical devices made in India, thereby reducing dependence on imports and giving an impetus to exports,” adds Purvang.